Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    cholangiocarcinoma AND biliary tract cancer | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors
Condition: Cholangiocarcinoma
Intervention:
2 Recruiting A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
Condition: Metastatic Biliary Tract Carcinoma
Intervention: Drug: Regorafenib
3 Recruiting Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer
Conditions: Cholangiocarcinoma;   Gall Bladder Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Other: Observation
4 Recruiting Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma
Conditions: Morbid Obesity;   Vertical Sleeve Gastrectomy;   Metabolic Syndrome;   Hepatocellular Carcinoma;   Cholangiocarcinoma;   Disorder of Bile Acid and Cholesterol Metabolism
Intervention:
5 Recruiting Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer
Conditions: Intrahepatic Cholangiocarcinoma;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Ampullary Carcinoma;   Biliary Obstruction
Interventions: Device: radioactive stent;   Device: plastic stent
6 Recruiting Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cholangiocarcinoma;   Ampullary Cancer
Interventions: Other: Active Symptom Control;   Drug: L-folinic acid;   Drug: 5 FU;   Drug: Oxaliplatin
7 Recruiting ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cholangiocarcinoma;   Ampullary Cancer
Interventions: Drug: Acelarin;   Drug: Cisplatin
8 Recruiting Pancreatico-biliary Tumor Mutation Profiling in Bile Samples
Condition: Cholangiocarcinoma, Cancer of the Head of the Pancreas
Interventions: Biological: bile sample analysis;   Biological: biochemical markers, VEGF and MMPs, in bile samples
9 Recruiting Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: CX-4945;   Drug: Cisplatin;   Drug: Gemcitabine
10 Recruiting ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Adenocarcinoma of the Gallbladder;   Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Gallbladder;   Duct Cell Adenocarcinoma of the Pancreas;   Localized Unresectable Adult Primary Liver Cancer;   Periampullary Adenocarcinoma;   Recurrent Adult Primary Liver Cancer;   Recurrent Gallbladder Cancer;   Recurrent Pancreatic Cancer;   Stage II Gallbladder Cancer;   Stage III Pancreatic Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Pancreatic Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer
Interventions: Drug: ADH-1;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis
11 Recruiting Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers
Condition: Biliary Tract Cancer
Interventions: Drug: Abraxane (Nab-Paclitaxel);   Drug: Cisplatin;   Drug: Gemcitabine;   Behavioral: Phone Calls
12 Recruiting Ramucirumab for Advanced Pre-treated Biliary Cancers
Condition: Biliary Cancer
Intervention: Drug: Ramucirumab
13 Recruiting Liver and Biliary Tumor Tissue Registry
Conditions: Hepatocellular Carcinoma;   Cholangiocarcinoma
Intervention:
14 Recruiting Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer
Conditions: Cholangiocarcinoma;   Gallbladder Carcinoma;   Biliary Carcinoma
Intervention: Drug: Gemcitabine-Pazopanib
15 Recruiting Phase 1/2 Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations
Condition: Solid Tumor
Intervention: Drug: ARQ 087
16 Recruiting Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
Conditions: Biliary Carcinoma;   Gall Bladder Carcinoma;   Cholangiocarcinoma;   Gastrointestinal Tumor
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Copanlisib
17 Recruiting A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
Conditions: Liver Cell Caricinoma;   Liver Cancer;   Hapatocellular Carcinoma;   Liver Neoplasms
Interventions: Drug: Durvalumab;   Drug: Tremelimumab;   Procedure: TACE;   Procedure: RFA;   Procedure: Cryoablation
18 Recruiting Extracellular RNA Markers of Liver Disease and Cancer
Conditions: Hepatocellular Carcinoma;   Biliary Tract Cancer;   Cirrhosis;   Liver Diseases
Intervention: Other: Blood samples
19 Recruiting In Vitro Models of Liver and Pancreatic Cancer
Conditions: Cholangiocarcinoma;   Hepatocellular Carcinoma;   Pancreatic Neoplasm
Intervention: Genetic: Organoid in vitro culture
20 Recruiting Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Conditions: Liver Cell Caricinoma;   Liver Cancer;   Hepatocellular Carcinoma;   Liver Neoplasms
Interventions: Drug: Tremelimumab;   Procedure: TACE;   Procedure: Radiofrequency Ablation (RFA);   Radiation: SBRT;   Procedure: Cryoablation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.